More evidence shows that EZH2 is strongly denoted in numerous tumors, including esophageal cancer (Qiu et al., 2020), gastric cancer (Gan et al., 2018), and endometrial carcinoma (Krill et al., 2020), which also contains BC (Bachmann et al., 2006). This evidence concerns the gene EZH2 and esophageal cancer.